Ripple CEO Brad Garlinghouse recently gave XRP holders some long-awaited good news: The Securities and Exchange Commission ...

Blockchain technology is receiving a boost with the XRP Ledger, based on recent findings from industry observers. The system has handled over 2.8 billion transactions without any security failure, ...

The XRP lawsuit settlement will mark a major milestone as the platform will see significant developments post the Ripple vs ...

XRP sees a significant price surge following regulatory clarity. With strong institutional interest and growing demand for ...

The opinions expressed are the author’s alone and have not been provided, approved, or otherwise endorsed by our partners.

The FDA has approved Alexion's Soliris for use in patients with treatment resistant generalised Myasthenia gravis (gMG), making it the first new therapy for the condition in 60 years. The approval ...

The opinions expressed are the author’s alone and have not been provided, approved, or otherwise endorsed by our partners.

XRP Price Trends: SEC Appeal Uncertainty Weighs on Demand On Tuesday, February 4, XRP slid by 6.44%, reversing a 4.81% gain from Monday, closing at $2.5283. Significantly, XRP underperformed the ...

Ethereum (ETH) and Ripple (XRP) also followed in BTC’s footsteps ... that Proof-of-Work mining rewards are not securities could boost BTC investors' confidence. Ripple is the third largest ...